Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Bevacizumab in the Treatment of Radiation Necrosis in Children With Central Nervous System Tumors

NCT01201850 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT01201850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01201850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Bevacizumab in the Treatment of Radiation Necrosis in Children With Central Nervous System Tumors
Lead sponsor
University of Colorado, Denver
Phase
Not applicable
Overall status
Terminated
Start date
June 28, 2010
Completion date
August 4, 2016
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

radiation necrosis